-
List of the most comprehensive CDE accelerated varieties
Time of Update: 2015-03-13
In 2014, it was reported that the National Drug Evaluation Center (CDE) would actively cooperate with the State Administration to promote the construction of priority evaluation system for generic dru
-
CDE: 2014 annual drug review report
Time of Update: 2015-03-13
In 2014, under the leadership of the State Food and drug administration, the drug review center of the State Food and Drug Administration (hereinafter referred to as the drug review center) continued
-
The state of new drug evaluation of Zhongyuan Xiehe blockbuster stem cells has gone back strangely
Time of Update: 2015-03-11
According to the website of the State Food and Drug Administration (CFDA), the review status of Zhongyuan Xiehe heavy-duty stem cell drug umbilical cord mesenchymal stem cell anti liver fibrosis injec
-
Drying 2014 drug approval report
Time of Update: 2015-03-10
Throughout the year, the number of chemical acceptance basically remained at about 80% of the total acceptance, while the number of application acceptance of traditional Chinese medicine decreased, an
-
Clinical application of Helicobacter pylori vaccine
Time of Update: 2015-03-10
According to the information on the website of the State Food and Drug Administration (CFDA), the clinical application of class 1 new drug of the Institute of bioengineering, Academy of Military Medic
-
Entenole, a new 1.1 breast cancer drug, enters CDE
Time of Update: 2015-03-09
Entenole is the first HDAC inhibitor to obtain positive results in phase II clinical randomized controlled trials of breast cancer Now, as a new drug of class 1.1, entenole is sponsored by CDE and ent
-
CDE drug review report in February 2015
Time of Update: 2015-03-09
Key points: • clinical application of 7 chemical 1.1 new drug varieties • clinical application of 6 chemical 1.1 new drug varieties • application of 3.1 new varieties by Jiangsu Haosen, Zhengda Tianqi
-
The first double dose "Viagra" generic drug, wanfile, obtained the production approval
Time of Update: 2015-03-06
It's better to rush into the Jianghu secretly than to show your strength Domestic "Viagra" needs to be bigger and better in internal skill Wanfile, the first dual dose Viagra generic drug developed by
-
Yabao Pharmaceutical Co., Ltd. and Lilai new diabetes drug ly26082047-august clinical application
Time of Update: 2015-03-05
Ren Wuxian, chairman of Yabao Pharmaceutical Co., Ltd., said on the sidelines of the two sessions of the pharmaceutical industry today that the research and development of diabetes drugs cooperated by
-
Somaglumetad methionil
Time of Update: 2015-03-05
Suoyuan biomedical (Hangzhou) Co., Ltd recently announced that its wholly-owned subsidiary, denovo biopharma, has signed an agreement with Lilly to obtain the global rights of the clinical phase III a
-
The new drug project of Changchun Baike biology and mucosis B.V. in the Netherlands is undergoing technology transfer
Time of Update: 2015-03-04
In 2014, bacco biology signed a relevant agreement with the Dutch company mucosis B.V., which invested 3.5 million euros in two phases to subscribe for mucosis B.V 25% of the company At the same time,
-
Tmb-355, a new AIDS drug from Zhongyu, a Taiwan based enterprise, was recognized by FDA as a breakthrough therapy
Time of Update: 2015-03-03
Breakthrough therapy design (BTD) was established by the U.S Food and Drug Administration (FDA) in July 2012 to accelerate the development and review of new drugs to treat serious or life-threatening
-
The recombinant Ebola virus vaccine obtained clinical approval within 20 days
Time of Update: 2015-03-03
The recombinant Ebola virus vaccine developed by the Institute of bioengineering, Academy of Military Medical Sciences, Chinese people's Liberation Army and Tianjin kangxinuo biotechnology was approve
-
Two potential new drugs of Hehuang pharmaceutical will be submitted to CFDA for approval in 2016
Time of Update: 2015-03-02
Backed by Li Ka Shing, one of Asia's richest men, and listed in London, Hutchison China Meditech said it was close to producing the first modern medicine developed in China in decades, the Financial T
-
Baiji Shenzhou 1.1 drug bgb-3111 was accepted by CDE
Time of Update: 2015-02-26
Beigene was jointly founded by Wang Xiaodong, academician of the National Academy of Sciences, and John oyler, an American with rich management experience It focuses on the field of tumor immunotherap
-
Tuohong medicine will cooperate with Jiangsu Provincial People's hospital to develop anti-tumor, anti-virus and other immune cell treatment technologies
Time of Update: 2015-02-26
Jiangsu tuohong Pharmaceutical Co., Ltd will work with Jiangsu People's hospital to develop anti-tumor, anti-virus and other immune cell treatment technologies, and develop affordable new anti-cancer
-
CDE drug review weekly report (2015.2.9-2.15)
Time of Update: 2015-02-18
Under the influence of the new year's atmosphere, only four drugs have entered the approval process this week, all of which are chemical drugs, including three drugs in 1.1 category and one drug in 6
-
Analysis on the market of hepatobiliary drugs in China in 2014
Time of Update: 2015-02-18
According to the pattern data of various categories of medicine, the national sales of anti-tumor and immunomodulators, systemic anti infective drugs, digestive system and Metabolic Drugs rank in the
-
Data analysis of diabetes drug research and development in China: 3.1 fierce competition in drug declaration
Time of Update: 2015-02-17
According to the latest issue of diabetes map released by the International Diabetes Federation, in 2013, there were 382 million adults suffering from diabetes in the world, and by 2035, the number of
-
[heavyweight] data analysis of new antitumor drugs development in China
Time of Update: 2015-02-16
According to the prediction of global cancer report 2014 released by the World Health Organization (who), global cancer cases will show a rapid growth trend, from 14 million in 2012 to 19 million in 2
